RISINGWired, AASM, Sleep FoundationMarch 2026🇺🇸 USHealthcare
😴

Sleep Apnea Often Goes Undetected in Women. That's Starting to Change.

Wired and sleep medicine experts report that ~75% of women with obstructive sleep apnea remain undiagnosed. Traditional screening tools like STOP-BANG were validated on men and miss female-typical symptoms: fatigue, insomnia, morning headaches, mood changes. The SARA (Sleep Apnea Risk Assessment) tool weights these factors and includes menopause status and pregnancy history.

Concept Fundamentals
75%
Women Undiagnosed
Sleep Foundation
2-3×
Menopause Risk
AASM
78%
SARA Sensitivity
High-risk
Wide
Detection Gap
STOP-BANG bias

Ready to run the numbers?

Why: Sleep apnea in women is massively underdiagnosed. STOP-BANG and similar tools favor snoring and observed apnea, which are less common in women. Women often present with fatigue, insomnia, and mood changes that get attributed to stress or menopause instead of OSA.

How: We implement a SARA-style algorithm that weights female-typical symptoms (fatigue, insomnia, morning headaches, mood changes) higher and includes menopause status, pregnancy history, and family history. Results are compared to a STOP-BANG equivalent to show the detection gap.

Your SARA risk score (0-100)Risk level (low/moderate/high/very-high)
Methodology
😴Women-Specific
Weights fatigue and insomnia higher than snoring
🌙Hormonal Factors
Menopause status and pregnancy history included
📊STOP-BANG Comparison
Shows how male-biased tools underdetect in women
Sources:WiredAASM

Run the calculator when you are ready.

Assess Your Sleep Apnea RiskWomen-specific SARA screening—fatigue and insomnia weighted higher than snoring

Demographics & Body

Symptoms

Hormonal & Family

sara_risk.sh
CALCULATED
SARA Score
70
Risk Level
very-high
STOP-BANG (equiv)
25
Sensitivity
78%

Very high risk. Urgent evaluation by a sleep specialist recommended. Untreated OSA increases cardiovascular and metabolic risk.

SARA detects higher risk than STOP-BANG (female symptoms weighted)

Share:
SARA Sleep Apnea Risk (Women-Specific)
70/100
very high Risk
Very high risk. Urgent evaluation by a sleep specialist recommended. Untreated OSA increases cardiovascular and metabolic risk.
numbervibe.com/calculators/trending/sleep-apnea-sara-calculator

SARA vs STOP-BANG Detection Rates by Gender

Symptom Contribution to SARA Score

Risk by Age and Menopausal Status

Detection Gap: Diagnosed vs Estimated Prevalence

For educational and informational purposes only. Verify with a qualified professional.

What is the SARA Sleep Apnea Risk Assessment?

SARA is a women-specific screening tool designed to address the detection gap. Approximately 75% of women with obstructive sleep apnea (OSA) remain undiagnosed because traditional tools like STOP-BANG were validated on male-dominated cohorts and emphasize snoring and observed apnea—symptoms more common in men. SARA weights fatigue, insomnia, morning headaches, and mood changes higher.

Women's OSA: The Hidden Epidemic

Wired reported: "Sleep Apnea Often Goes Undetected in Women. That\'s Starting to Change." Women present with different symptoms—fatigue, insomnia, restless legs, depression-like mood—that clinicians often attribute to stress or hormones rather than OSA. Upper airway anatomy and hormonal factors also differ.

😴75% of women with OSA are undiagnosedSource: Sleep Foundation
🩺Menopause increases OSA risk 2-3×Source: AASM
🤰Pregnancy raises OSA risk from weight and airway changesSource: Springer
😔Depression overlap: many "depressed" women have untreated OSASource: Pulmonary Therapy

SARA vs STOP-BANG: Why It Matters

STOP-BANG asks about Snoring, Tiredness, Observed apnea, Pressure (BP), BMI, Age, Neck, Gender. It underperforms in women because tiredness is vague and observed apnea (partner-reported) is less common. SARA explicitly weights fatigue and insomnia, includes menopause status, pregnancy history, and mood changes.

FactorSARA (Women)STOP-BANG
FatigueHigh weightLow (T only)
InsomniaIncludedNot included
MenopauseIncludedNot included
Mood changesIncludedNot included
SnoringModerateHigh
Observed apneaModerateHigh

Hormonal Factors in Women's OSA

  • Menopause: Estrogen and progesterone protect upper airway tone. Decline increases collapse risk.
  • Pregnancy: Weight gain, nasal congestion, and supine sleep raise apnea risk.
  • PCOS: Insulin resistance and obesity are linked to higher OSA prevalence.
  • Hormone replacement: May reduce OSA severity in some postmenopausal women.

When to Get a Sleep Study

Polysomnography (in-lab) or home sleep apnea testing is recommended when clinical suspicion is high. Indications: persistent fatigue despite 7+ hours sleep, witnessed apnea, hypertension, BMI >30, neck circumference >15.5 in (women), or high screening score.

Treatment Options

CPAP

First-line. Improves AHI, daytime sleepiness, cardiovascular outcomes.

Oral Appliances

Mandibular advancement devices for mild-moderate OSA.

Lifestyle

Weight loss, positional therapy, avoid alcohol before bed.

Inspire

Hypoglossal nerve stimulator for CPAP-intolerant patients.

Key Statistics

75%
Women with OSA undiagnosed
26%
Adults with OSA (est.)
2-3×
Menopause OSA risk
78%
SARA sensitivity (high risk)

⚠️ Medical Disclaimer: This calculator is for educational and screening purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. SARA is a screening tool—only a sleep study (polysomnography or home sleep apnea test) can diagnose OSA. If you have symptoms of sleep apnea, consult your doctor or a sleep specialist. Never disregard professional medical advice because of information from this calculator.

Related Calculators